Breast & Prostate Cancer (posters)

SAT-294

A Positive Feedback Mechanism Between Estrogen and Tnfα in An ER+ Breast Tumour Microenvironment
Sarah Quynh Giao To, Kevin Christopher Knower and Colin D Clyne

SAT-296

Progestin Gene Regulation in Dual PR/AR Positive Breast Tumors
Jessica A Finlay-Schultz, Peter Hendricks, Rachel B Rosen, Kale Flory, Anthony Elias, Britta M Jacobsen, Peter Kabos and Carol A Sartorius

SAT-297

SAT-299

A comparison of an androgenic pathway between development and reoccurrence/progression of triple negative breast cancer patients
Keely M McNamara, Alif Meem Nurani, Tomomi Yoda, Yasuhiro Miki, Niramol Chanplakorn, Eriko Abe, Yang Yang, Hideko Yamauchi, Koyu Suzuki, Hisashi Hirakawa, Reiki Nishimura, Nobuyuki Arima, Takashi Suzuki, Minoru Miyashita, Kentaro Tamaki, Takanori Ishida, Noriaki Ohuchi and Hironobu Sasano

SAT-300

Endogenous Circadian Clocks in Canine Mammary Tumor Cells Modulate Expression of Estrogen Receptor beta (ERβ)
Shay Bracha, Kelly Hughes, Cheri Peyton Goodall and Patrick Everett Chappell

SAT-301

Blockade Of Growth Hormone Receptor Inhibits HER2 Overexpressing Breast Cancer Cell Proliferation
Arunkumar Arumugam, Thiyagarajan Boopalan, Sushmita B Nandy, Rebecca Lopez, Christina Gutierrez and Rajkumar Lakshmanaswamy

SAT-302

Persistent alteration of microRNA expression in hypothalamo-pituitary axis results in the reduction of breast cancer risk
Sushmita B Nandy, Arunkumar Arumugam, Thiyagarajan Boopalan, Rebecca Lopez, Christina Gutierrez and Rajkumar Lakshmanaswamy

SAT-303

SAT-304

Progesterone activates USF-1 in estrogen induced mammary carcinogenesis
Thiyagarajan Boopalan, Arunkumar Arumugam, Sushmita B Nandy, Rebecca Lopez, Christina Gutierrez and Rajkumar Lakshmanaswamy

SAT-306

Tumor Suppressor miR-16 Is Modulated by ErbB-2 in Breast Cancer and May Serve as an Alternative Therapy for Trastuzumab-Resistant Breast Carcinoma
Leandro Venturutti, Martin Alfredo Rivas, Rosalia Ines Cordo Russo, Tim H-M Huang, Roxana Schillaci and Patricia Virginia Elizalde

SAT-308

SAT-309

ESTRADIOL ENHANCES GOLD NANOPARTICLES INCORPORATION IN MCF-7 BREAST CANCER CELLS BY MODIFYING MEMBRANE ROUGHNESS
Carlos Lara-Cruz, Javier E. Jiménez-Salazar, Roberto C. Lazzarini-Lechuga, Leticia González-Núñez, Nikola Batina, Eva Ramón-Gallegos and Pablo Damian-Matsumura

SAT-310

The ghrelin receptor antisense gene, GHSROS, in breast cancer progression
Patrick Thomas, Eliza J. Whiteside, Andrew Stacey, Adrian C. Herington, Lisa K. Chopin and Inge Seim

SAT-312

Glucocorticoid receptor antagonism as a novel treatment for triple negative breast cancer
Maxwell N. Skor, Paul A. Volden, Abena S. Agyeman, Elizabeth A. Duckworth and Suzanne D. Conzen

SAT-313

Targeting nuclear ErbB-2 function in trastuzumab-resistant breast cancer cells
Rosalia Ines Cordo Russo, Wendy Béguelin, María Celeste Díaz Flaqué, Natalia M Galigniana, Cecilia J Proietti, Leandro Venturutti, Eduardo Hernán Charreau, Roxana Schillaci and Patricia Virginia Elizalde

SAT-315

Ginkgo biloba extract, a possible aromatase inhibitor in breast cancer
Yong Joo Park, Sol Park, Kyu Hyuck Chung and Seung Min Oh

SAT-316

Inhibitory effects of flavonoids in ginkgo biloba extract on aromatase activity
Yong Joo Park, Min Sun Yi, Kyu Hyuck Chung and Seung Min Oh

SAT-319

SAT-320

CUDC101 is a new powerful inhibitor of the androgen receptor variant AR-V7
Huyiyng Sun, Sanjay Navin Mediwala, Erica V Gonzalez, Adam T Szafran, Michael Alan Mancini and Marco Marcelli

SAT-321

MECHANISM OF WARFARIN ACTION IN PROSTATE CANCER
Ben Yi Tew, Maya Otto-Duessel, Miaoling He, Sumanta Pal, Tommy Tong, Huiqing Wu and Jeremy Jones

SAT-324

Serotonin receptor 4 (5-HTR4) regulates expression of ER beta (ERβ) and cell growth in human prostate cancer
Yasuhiro Nakamura, Kazue Ise, Saulo JA Felizola, Keely M McNamara and Hironobu Sasano

SAT-325

Using Explant Technology to Discover Markers of Response to Hsp90 Inhibitors in Prostate Cancer
Margaret M Centenera, Natalie K Ryan, Shalini Jindal, Florian Weiland, Peter Hoffmann, Wayne D Tilley and Lisa Maree Butler